TrialJAMA cardiology2020

Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span: Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).

Muthiah Vaduganathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.